Additional filters Number of results: 9
Sandra Margetić
Iva Ivanko, Milena Hanžek, Ivana Ćelap, Sandra Margetić, Domagoj Marijančević, Josipa Josipović, Petar Gaćina
Original articles, Volume 34, October, Issue 3
KEYWORDS: chemokine; vaccine; immunity
https://doi.org/10.11613/BM.2024.030706
Ana Bronić, Sandra Margetić, Desiree Coen Herak, Marija Milić, Branka Krešić, Vanja Radišić Biljak, Jasna Leniček Krleža
Original Articles, Volume 31, June, Issue 2
KEYWORDS: activated partial thromboplastin time; external quality assessment; harmonization
https://doi.org/10.11613/BM.2021.020708
Ivana Ćelap, Sandra Margetić, Marija Brčić, Roman Mihić
Original Articles, Volume 30, February, Issue 1
KEYWORDS: chromogenic assay; dabigatran; rivaroxaban; apixaban; method comparison
https://doi.org/10.11613/BM.2020.010706
Sandra Margetić, Ivana Ćelap, Diana Delić Brkljačić, Nikola Pavlović, Sandra Šupraha Goreta, Ivana Kobasić, Arijana Lovrenčić-Huzjan, Vanja Bašić Kes
KEYWORDS: apixaban; DOAC; factor Xa inhibitors; LMWH; rivaroxaban
https://doi.org/10.11613/BM.2020.010702
Ana Bronić, Desiree Coen Herak, Sandra Margetić, Marija Milić
Review, Volume 29, June, Issue 2
KEYWORDS: blood coagulation tests; haemostasis; standardization; harmonization; guidelines
https://doi.org/10.11613/BM.2019.020503
Original Papers, Volume 27, February, Issue 1
KEYWORDS: survey; haemostasis; blood coagulation tests
https://doi.org/10.11613/BM.2017.022
Sandra Margetić, Ivana Ćelap, Lora Dukić, Ines Vukasović, Lucija Virović-Jukić
Case Report, Volume 26, June, Issue 2
KEYWORDS: prothrombin time; interference; M-protein; monoclonal gammopathy; thrombin time
https://doi.org/10.11613/BM.2016.028
Sandra Margetic
Review, Volume 22, February, Issue 1
KEYWORDS: inflammation; haemostasis; inflammation mediators; atherosclerosis; sepsis
https://doi.org/10.11613/BM.2012.006
Sandra Margetić, Biserka Raić, Tomislav Franjo Hajnžić, Nikola Bulj, Elizabeta Topić, Andrea Tešija-Kuna, Nora Nikolac
Case report, Volume 16, December, Issue 2
KEYWORDS: venous thromboembolism; antiphospholipid syndrome; PAI-1 polymorphism
https://doi.org/10.11613/BM.2006.018